HADPOP Flashcards

1
Q

Define crude birth rate

A

Number of live births per 1000 population

Describes impact of birth on size of population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define general fertility rate

A

Number of live births per 1000 females aged 15-44

compares fertility of fertile female populations
Affected by age-specific fertility rate & age distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define total period fertility rate

A

Average number of children born to a hypothetical woman in her life

Compares fertility of fertile females without being influenced by age or group stucture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the determinants of fertility

A

Fecundity: physical ability to reproduce
Fertility: realisation of this potential as births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define crude death rate

A

Number of deaths per 1000 population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define age-specific death rate

A

Number of deaths per 1000 people in a given age group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is standardised mortality ratio

How do you calculate it

What are its advantages

A

Compares number of deaths with expected number of deaths (if age-sex distribution of the population in identical)

Observed number of deaths / expected (x 100)

Provides overall mortality ratio adjusted for different distributions of factors e.g. Age, sex in populations
Compares death rates by applying same population age structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you calculate incidence / incidence rate

What are its advantages

A

Number of new cases / person-years (no of people x no of yrs)

Number of cases / population number x 1000

Focuses on new events, monitors epidemics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is prevalence
How do you calculate it
What are its advantages

A

A proportion not a rate

Number of people affected (old & new) / total population number
(X 100 for percentage)

Describes burden
Measure service needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is incidence rate ratio
How do you calculate it
How do you interpret it

A

Compares number of cases per population per unit time

Rate b (exposed) / rate a (unexposed)

Compare IR between groups with different levels of exposure
Make sure person years are the same for both

If rate b higher = difference in exposures associated with different rates of disease
b > a = IR > 1
b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
What figures do you use in error factor calculation for:
IR / prevalence
IRR
SMR
OR
A

d= no of events observed (not a rate)

d1 & 2 = no of events in each population

O = observed no of cases

a= cases exposed, b= controls exposed, c= cases unexposed, d= controls unexposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interpreting confidence intervals:
If range doesnt include null hypothesis (1)
If range does include null hypothesis (1)

A

Can reject null
Data inconsistent with hypothesis

Cannot reject null
Data consistent with hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe:
Systematic variation
Random variation

A

Variation attributed to particular factors

Variation cant be explained (e.g. By chance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cohort studies:
Describe characteristics
Advantages
Disadvantages

A

Recruit disease free individuals
Follow them over time & count how many develop disease (person yrs)
Comparative: risk one group vs another
Prospective or historical

Study rare exposures/characteristics
More detailed info on outcomes & exposures
Collect additional info on potential confounders

Large/resource intensive
Time consuming
Risk loss to follow up
Not good for rare outcomes
Confounding (unknown)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cohort studies:
How is risk estimated
How can comparisons be made

A

Incidence rate in each group

Exposed & unexposed:
Subdivide levels of exposure & compare with relative risk (IRR)
Compare to external reference population (SMR)

(Error factor for internal comparison larger than for external)
(External comparison usually have less random variation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Case control studies:
Characteristics
Advantages
Disadvantages

A

Identify group already ill (cases) & group that are not (controls)
Look back to compare exposure status (generally retrospecitve)
Identify exposure & compare disease outcome
Prevalence fixed by study design/number of participants;
Estimates relative (not absolute) risk

Good for rare diseases
Can look @ different exposures once, for single outcome/disease
Quicker, cheaper

Not good for rare exposures
Selection bias: recall, finding representative comparison population
Info bias: info on exposure, randomly inaccurate measurement, systematic (e.g. Different data collection), interviewer bias
Confounding: minimise with matching for confounders & logistic reg

17
Q

Odds ratio (for case control & cohort):
How to calculate
What it shows

Effects on OR if:
Cases underestimate more than controls
Controls underestimate more than cases
Both cases & controls underestimate randomly

A

Table: cases & controls across top, exposed & unexposed down side
(axd) / (bxc)

Estimates relative risk (like IRR)
compare oods of being exposed in cases vs odds of being exposed in controls
Increase precision by increasing number of controls (reduced EF); usually 5 x number of cases

Bias OR towards underestimation of affect of outcome
Bias OR towards overestimation of affect of outcome
Shrinkage towards null

18
Q

Define chance: 95% confidence interval & P value

A

95% chance that true value lies within range

How likely results would have occurred by chance if the null was true

19
Q

Define bias

What are the types of bias

A

Deviation of results / inferences from truth; invalidates conclusins

Selection bias:
correct info, wrong people
Characteristics of groups & the way they are selected

Information bias:
Incorrect info, right people
Measurement/classification into groups

Recall bias

Each may be:
Systematic (results skewed in particular direction)
Non-systematic (random errors, CI wider, IR towards 1)

20
Q

Define confounding

A

Characteristic of the population, linked to exposure & outcome

Measure of effect of exposure on risk of outcome being distorted

21
Q

Define reverse causality

A

Cause-effect relationship exists in the opposite direction

22
Q

How do you distinguish causal from non-causal association

A

Hypothesis: from observation / clinical practice & studies

Analytical study: test hypothesis

Observed association: test validity, exclude alternative explanations (chance, bias, confounding)

Does statistical association represent cause-effect relationship?:
Infer beyond data in light of current knowledge

23
Q

Census: definition

A
Simultaneous recording 
Of demographic data
By government
@ particular time
Re: all people with live in a particular country
24
Q

Cause-effect relationship:
What are Henle-Koch’s Postulates
What are their limitations

A

Agent present in every case by isolation in pure culture
Agent not found in any other diseases
Agent able to reproduce disease in experimental conditions in experimental animals (once isolated)

Diseases are multifactorial; exposure can cause many diseases

25
Q

Evaluating strength of evidence in the cause-effect relationship:
What are the Bradford Hill criteria for inferring causality

A
Strength of association
Specificity of association
Consistency of association
Temporal sequence
Dose response (biological gradient)
Reversibility (strongest criterion)
Coherence of theory
Biological plausibility
Analogy
26
Q

Randomised control trials:
What is the purpose of a clinical trial
Why do you not use historical controls

A

Fair, controlled, comparative, reproducible study to clarify the most appropriate treatment of future patients

Selection criteria less well defined/rigorous
May have been treated in different/other ways
Less information about patients, therefore difficult to adjust for confounders

27
Q

Randomised control trials:
What are the steps involved
Why are participants randomly allocated to groups
Why use blinding (& what are the types of blinding)

A

Answer question: is new treatment better of worse than the usual/standard treatment?
Identify, recruit, consent & maintain 2 comparable groups
Allocate, follow up, assess & compare

Minimise allocation bias & confounding (known & unknown)

Minimise non treatment effect & measurement bias
(Single or double blind)

28
Q

Randomised control trials:
What is the definition of placebo
Why is it used

A

Inert substance that looks/tastes/is packaged identically

Eliminate placebo effect (psychological benefit of being treated)

29
Q

Randomised control trials:

Features of suitable outcome measures

A

Measured by assessor
Blind to treatment status
Relevant, objective, valid, sensitive, reliable, practical

30
Q

Randomised control trials:
How do you minimise losses to follow up
How do you maximise compliance

A

Sufficient/clear info on what is involved
Follow up not too onerous

Clear, simple instruction
Check on compliance

31
Q

Randomised control trials:

What are the types of analysis

A

As treated: but no longer randomly allocated / immune to follow up (e.g. Assess drug physiology)

Intention to treat: realistic indication of impact of treatment
Randomisation preserved & confounding avoided

32
Q

Randomised control trials:
What are the ethical principals of research
What are the issues in making a clinical trial ethical
What is the role of the Research & Ethics committee

A

Declaration of Helsinki: health of patient 1st consideration
Collective ethic: all patients should have treatment tested for efficacy/safety
Individual ethic: RCTs for benefit of future patients

Voluntariness
Valid consent
Ethical recruitment
Scientifically robust
Clinical equipoise (uncertainty about better treatment)

Involved NHS trust & PCT research & development office
Focus on: scientific design/conduct, recruitment, care & protection, confidentiality, informed consent, community consideration